Intuitive Surgical Inc banner

Intuitive Surgical Inc
LSE:0R29

Watchlist Manager
Intuitive Surgical Inc Logo
Intuitive Surgical Inc
LSE:0R29
Watchlist
Price: 407.52 USD 0.76% Market Closed
Market Cap: $46.5B

Wall St Price Targets

0R29 Price Targets Summary
Intuitive Surgical Inc

Wall Street analysts forecast 0R29 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 0R29 is 589.6 USD with a low forecast of 374.15 USD and a high forecast of 797.07 USD.

Lowest Forecast
Price Target
374.15 USD
8% Downside
Average Forecast
Price Target
589.6 USD
45% Upside
Highest Forecast
Price Target
797.07 USD
96% Upside
Intuitive Surgical Inc Competitors:
Price Targets
GWH
ESS Tech Inc
158% Upside

Revenue
Forecast

13% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
13% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 15%.

Gross Profit
Forecast

13% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
13% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 14 years, the compound annual growth rate for Gross Profit has been 13%. The projected CAGR for the next 3 years is 16%.

Operating Income
Forecast

11% / Year
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
-24%
Average Miss
11% / Year
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
-24%
Average Miss

Over the last 14 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is 26%.

Pre-Tax Income
Forecast

12% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-21%
Average Miss
12% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-21%
Average Miss

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 24%.

Net Income
Forecast

13% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss
13% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Over the last 14 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 3 years is 20%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 0R29's stock price target?
Price Target
589.6 USD

According to Wall Street analysts, the average 1-year price target for 0R29 is 589.6 USD with a low forecast of 374.15 USD and a high forecast of 797.07 USD.

What is the Revenue forecast for Intuitive Surgical Inc?
Projected CAGR
15%

Over the last 14 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 15%.

What is the Gross Profit forecast for Intuitive Surgical Inc?
Projected CAGR
16%

Over the last 14 years, the compound annual growth rate for Gross Profit has been 13%. The projected CAGR for the next 3 years is 16%.

What is the Operating Income forecast for Intuitive Surgical Inc?
Projected CAGR
26%

Over the last 14 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is 26%.

What is the Pre-Tax Income forecast for Intuitive Surgical Inc?
Projected CAGR
24%

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 24%.

What is the Net Income forecast for Intuitive Surgical Inc?
Projected CAGR
20%

Over the last 14 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 3 years is 20%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett